Skip to main content
. 2000 Nov;44(11):3112–3117. doi: 10.1128/aac.44.11.3112-3117.2000

TABLE 2.

Fluoroquinolone growth inhibition of S. pneumoniae strain 7785 and drug-stimulated DNA cleavage efficiencies of DNA gyrase and topoisomerase IV

Drug MIC (μg/ml) for strain 7785 CC25 (μM) for DNA breakagea
Gyrase Topoisomerase IV
Ciprofloxacin 1–2 80 2.5
Gemifloxacin 0.06 5 0.1
a

CC25, concentration of drug that converts 25% of the substrate DNA to the linear form in the presence of gyrase or topoisomerase IV.